A Study of Toripalimab Injection (JS001) + Cetuximab in Treatment of Advanced Head and Neck Squamous Cell Cancer
Clinical trial NCT04856631 · COMPLETED
Trial details
- NCT number
- NCT04856631
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-06
- Primary completion
- 2024-10-25
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.